Xeris Biopharma Holdings, Inc. is a company in the U.S. stock market and it is a holding in 12 U.S.-traded ETFs. XERS has around 1.7M shares in the U.S. ETF market. The largest ETF holder of XERS is the Vanguard Total Stock Market ETF (VTI), with approximately 782.24K shares. Investors may also find of interest that the ETF with the largest allocation to XERS stock is Direxion Low Priced Stock ETF (LOPX), with a portfolio weight of 2.03%. On average, U.S. ETFs allocate 0.19% of XERS to their portfolios.

Additionally, XERS is a favorite stock for Vanilla and Active ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with XERS as a holding is the Avantis U.S. Equity ETF (AVUS), with a return of 0.16%.